CLOs on the Move

Anavasi Diagnostics

www.anavasi.com

 
Anavasi Diagnostics is a medical technology company focused on saving lives by developing novel molecular diagnostic testing using a proprietary patent-pending reverse transcriptase methodology. It was founded by world-leading university researchers, top medical device and clinical diagnostics engineering and design executives, manufacturing experts and a former Microsoft software veteran. Throughout their careers, the team has altogether been responsible for the introduction of more than forty medical/diagnostic products and over 350 peer-reviewed research publications.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.anavasi.com
  • 4000 Mason Road
    Seattle, WA USA 98195
  • Phone: 888.262.8274

Executives

Name Title Contact Details

Similar Companies

ADCO Hearing Products

ADCO Hearing Products is a Englewood, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Midway Dental Supply Inc

Midway Dental Supply Inc is a Lakeville, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Healthy.io

Healthy.io transforms the smartphone camera into a medical device to deliver healthcare at the speed of life. The company`s at-home urinalysis and digitized wound care services enable providers and healthcare systems to close gaps in access and care while increasing patient satisfaction. Healthy.io is a global leader in digital health and is a recipient of the CNBC 2020 Disruptor 50 Award, Fast Company`s World`s Most Innovative Companies 2020 Award, and the Financial Times 2020 Boldness in Business Award. The company is based in Tel Aviv and has offices in Boston and London.

EIDAM DIAGNOSTICS CORPORATION

EIDAM DIAGNOSTICS CORPORATION is a Richmond, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Novadaq

Enabling surgeons with clinically-relevant, innovative fluorescence imaging solutions to enhance the lives of patients and their surgeons, while reducing health care costs, is Novadaq’s global mission. SPY fluorescence imaging technology provides surgeons with real-time visualization, leading to improved outcomes and reduced costs without exposing the patient to harmful ionizing radiation or contrast dye toxicity. More than 130 peer-reviewed publications demonstrate that the use of SPY during complex surgery, leads to fewer post-operative complications and lower hospital costs. The SPY Imaging System is United States Food and Drug Administration (“FDA”) 510(k) cleared for use in seven surgical specialties. The endoscopic version of SPY called PINPOINT®, combines the capabilities of SPY Imaging with high definition (“HD”) visible light visualization offered by conventional endoscopes. Our unique business model of partnering with market-leading companies to drive adoption of our fluorescence imaging technology, while building our own commercial infrastructure is the cornerstone of our corporate strategy for growth.